StockWatch
·
Pharmaceuticals
ESG25 Aug 2026, 05:50 pm

Zydus Lifesciences ESG Score Rises to 66

AI Summary

Zydus Lifesciences Ltd has received an improved ESG score of 66 from CRISIL Ratings Limited, up from 61 previously. This score, based on data for the financial year 2025-2026, places the company in the 'strong' category (61-70) according to CRISIL's framework. The company has disclosed this rating in compliance with SEBI regulations.

Key Highlights

  • ESG score improved to 66 from 61.
  • Score is based on FY 2025-2026 data.
  • CRISIL rates the score as 'strong'.
  • Disclosure complies with SEBI regulations.